http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7993878

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 676
issn 1096-7192
issueIdentifier 4
pageRange 672-676
publicationName Molecular Genetics and Metabolism
startingPage 672
bibliographicCitation Gordon P, Thomas JA, Suter R, Jurecki E. Evolving patient selection and clinical benefit criteria for sapropterin dihydrochloride (Kuvan®) treatment of PKU patients. Molecular Genetics and Metabolism. 2012 Apr;105(4):672–6. doi: 10.1016/j.ymgme.2011.12.023.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_44a7c6e6496d0f2e7d81671efa691bc5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0e8808c8ae6a4808ad8c50c7c7fe6895
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_84ccd990ca8db7d5521e446fd366586c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed62d14951aa14401ee63194bc8e99f8
date 201204
identifier https://pubmed.ncbi.nlm.nih.gov/22310224
https://doi.org/10.1016/j.ymgme.2011.12.023
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20853
https://portal.issn.org/resource/ISSN/1096-7192
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Evolving patient selection and clinical benefit criteria for sapropterin dihydrochloride (Kuvan®) treatment of PKU patients
discusses http://id.nlm.nih.gov/mesh/M000758886
http://id.nlm.nih.gov/mesh/M0044450
http://id.nlm.nih.gov/mesh/M0014877
http://id.nlm.nih.gov/mesh/M0016544
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6140
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398654
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135409471

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136135466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128490606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127654813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129421946

Total number of triples: 33.